A Study of CLR325 in Chronic Stable Heart Failure Patients.
Status:
Completed
Trial end date:
2019-01-14
Target enrollment:
Participant gender:
Summary
The purpose of this study was to determine the safety and tolerability of CLR325 intravenous
(i.v.) infusion in patients with stable heart failure to determine if further clinical
development of the drug in this indication was warranted.